BYSI vs MCRB
Comparison between BeyondSpring Inc (BYSI, Company) and Seres Therapeutics Inc (MCRB, Company).
Both BYSI and MCRB are from the Healthcare sector.
5-Year PerformanceBYSI has outperformed MCRB, delivering a return of -34.2% compared to -58.3%
BYSI vs MCRB - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
BYSI vs MCRB - Historical Returns
Returns include dividend reinvestment.
BYSI vs MCRB - Annual Returns (2015 - 2026)
Returns include dividend reinvestment.
| Year | BYSI | MCRB |
|---|---|---|
| 2026 | -22.36% | -65.35% |
| 2025 | +2.52% | -11.78% |
| 2024 | +90.42% | -40.64% |
| 2023 | -48.57% | -74.07% |
| 2022 | -62.48% | -36.65% |
| 2021 | -62.75% | -66.76% |
| 2020 | -21.29% | +631.34% |
| 2019 | -16.40% | -28.57% |
| 2018 | -35.34% | -57.16% |
| 2017 | +73.09% | +1.30% |
| 2016 | N/A | -70.97% |
| 2015 | N/A | -31.73% |
BYSI vs MCRB Drawdown Comparison
The maximum drawdown for BYSI was -98.83%, occurring on Dec 8, 2022. This drawdown has not yet recovered.
The maximum drawdown for MCRB was -99.50%, occurring on Jul 20, 2026. This drawdown has not yet recovered.
The current BYSI drawdown is -97.41%. The current MCRB drawdown is -99.49%.
| Rank | BYSI | MCRB |
|---|---|---|
| #1 | -98.83% Jul 3, 2017 - Dec 8, 2022 | -99.50% Jun 26, 2015 - Jul 20, 2026 |
| #2 | -31.39% Jun 6, 2017 - Jul 3, 2017 | N/A |
| #3 | -6.91% Mar 13, 2017 - Mar 17, 2017 | N/A |
| #4 | -6.57% Mar 17, 2017 - Mar 31, 2017 | N/A |
| #5 | -4.33% May 4, 2017 - May 16, 2017 | N/A |
| #6 | -1.97% May 16, 2017 - May 18, 2017 | N/A |
| #7 | -1.44% Apr 27, 2017 - May 2, 2017 | N/A |
| #8 | -0.85% Mar 31, 2017 - Apr 7, 2017 | N/A |
| #9 | -0.75% Apr 7, 2017 - Apr 13, 2017 | N/A |
| #10 | -0.60% Apr 21, 2017 - Apr 26, 2017 | N/A |
| #11 | -0.51% Apr 19, 2017 - Apr 21, 2017 | N/A |
| #12 | -0.39% May 25, 2017 - May 30, 2017 | N/A |
Correlation
Correlation between BYSI and MCRB is 0.41 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks